The hedge fund Visium Asset Management is being investigated by the Justice Department and the Securities and Exchange Commission, the New York Times DealBook Blog reported yesterday. The agencies have requested information from several years ago relating to Visium’s valuation of certain securities in a credit fund it shut down in 2013. The authorities are also looking at Visium’s trading of certain securities and the firm’s use of a consultant more than five years ago. Visium is an $8 billion, New York-based hedge fund that focuses on investments in pharmaceutical companies. It was one of more than a handful of hedge funds that were invested in Valeant last year, but it sold the last of its shares in the fourth quarter of 2015, according to regulatory filings.
